<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23274" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hyponatremia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rondon</surname>
            <given-names>Helbert</given-names>
          </name>
          <aff>University of Pittsburgh</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Badireddy</surname>
            <given-names>Madhu</given-names>
          </name>
          <aff>Christus Santa Rosa Hospitals</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Helbert Rondon declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Madhu Badireddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23274.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hyponatremia is defined as a serum sodium concentration of less than 135 mEq/L but can vary to a small extent in different laboratories. Hyponatremia is a common electrolyte abnormality caused by an excess of total body water when compared to total body sodium content. Edelman discovered that serum sodium concentration does not depend on total body sodium but the ratio of total body solutes (e.g., total body sodium and total body potassium) to total body water. Hyponatremia represents an imbalance in this ratio where total body water is more than total body solutes. This activity explains when this condition should be considered on differential diagnosis, articulates how to properly evaluate for this condition, and highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of hyponatremia.</p></list-item><list-item><p>Describe the pathophysiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and its association with hyponatremia.</p></list-item><list-item><p>Summarize the treatment of hyponatremia.</p></list-item><list-item><p>Outline the importance of enhancing care coordination among the interprofessional team to ensure proper evaluation and management of hyponatremia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23274&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23274">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23274.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hyponatremia is defined as a serum sodium concentration of less than 135 mEq/L but can vary to some extent depending upon the set values of varied laboratories.<xref ref-type="bibr" rid="article-23274.r1">[1]</xref> Hyponatremia is a common electrolyte abnormality caused by an excess of total body water in comparison to that of the total body sodium content. Edelman approved of the fact that serum sodium concentration does not depend on total body sodium but is determined by the ratio of total body solutes (e.g., total body sodium and total body potassium) to total body water.<xref ref-type="bibr" rid="article-23274.r2">[2]</xref> Hyponatremia represents an imbalance in this ratio where total body water is more than total body solutes. Total body water (TBW) has two main compartments, extracellular fluid (ECF), accounting for one-third, and intracellular fluid (ICF), accounting for the remaining two-thirds. Sodium is the major solute of ECF, and potassium for ICF.</p>
      </sec>
      <sec id="article-23274.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of hyponatremia can be classified based on the volume status of the extracellular fluid. As mentioned earlier, sodium is the major solute of extracellular fluid (ECF). Based on the volume of ECF, a patient can be classified into hypovolemic, euvolemic, or hypervolemic.<xref ref-type="bibr" rid="article-23274.r3">[3]</xref></p>
        <p>Physiological stimuli that cause vasopressin release in adjunct with increased fluid intake can cause hyponatremia. Hypothyroidism&#x000a0;and adrenal insufficiency may contribute to an increased release of vasopressin.&#x000a0;Physiological stimuli for vasopressin release include loss of intravascular volume (hypovolemic hyponatremia) and the loss of effective intravascular volume (hypervolemic hyponatremia).</p>
        <p>
<bold>Causes of Hypovolemic Hyponatremia (TBW decreases less than a decrease in total body sodium)</bold>
<xref ref-type="bibr" rid="article-23274.r4">[4]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastrointestinal fluid loss (diarrhea or vomiting)</p>
          </list-item>
          <list-item>
            <p>The third spacing of fluids (pancreatitis, hypoalbuminemia, small bowel obstruction)</p>
          </list-item>
          <list-item>
            <p>Diuretics</p>
          </list-item>
          <list-item>
            <p>Osmotic diuresis (glucose, mannitol)</p>
          </list-item>
          <list-item>
            <p>Salt-wasting nephropathies</p>
          </list-item>
          <list-item>
            <p>Cerebral salt-wasting syndrome (urinary salt wasting, possibly caused by increased brain natriuretic peptide)</p>
          </list-item>
          <list-item>
            <p>Mineralocorticoid deficiency</p>
          </list-item>
        </list>
        <p>
<bold>Causes of Hypervolemic Hyponatremia (TBW increases greater than an increase in total body sodium)</bold>
<xref ref-type="bibr" rid="article-23274.r5">[5]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Renal causes (acute renal failure, chronic renal failure, nephrotic syndrome)</p>
          </list-item>
          <list-item>
            <p>Extrarenal causes (congestive heart failure, cirrhosis)</p>
          </list-item>
          <list-item>
            <p>Iatrogenic</p>
          </list-item>
        </list>
        <p>
<bold>Causes of Euvolemic Hyponatremia (TBW increase with stable total body sodium)</bold>
</p>
        <p>Nonosmotic, pathologic vasopressin release may occur in the setting of normal volume status, as with euvolemic hyponatremia.</p>
        <p>Causes of euvolemic hyponatremia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Drugs, as mentioned below.</p>
          </list-item>
          <list-item>
            <p>Syndrome of inappropriate antidiuretic hormone (SIADH)</p>
          </list-item>
          <list-item>
            <p>Addison's disease</p>
          </list-item>
          <list-item>
            <p>Hypothyroidism</p>
          </list-item>
          <list-item>
            <p>High fluid intake in conditions like primary polydipsia; or potomania, caused by a low intake of solutes with relatively high fluid intake</p>
          </list-item>
          <list-item>
            <p>Medical testing related to excessive fluids, such as a colonoscopy or cardiac catheterization<xref ref-type="bibr" rid="article-23274.r6">[6]</xref><xref ref-type="bibr" rid="article-23274.r7">[7]</xref><xref ref-type="bibr" rid="article-23274.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Iatrogenic</p>
          </list-item>
        </list>
        <p>Many drugs cause hyponatremia, and the most common include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vasopressin analogs such as desmopressin and oxytocin</p>
          </list-item>
          <list-item>
            <p>Medications that stimulate vasopressin release or potentiate the effects of vasopressin, such as selective serotonin-reuptake inhibitors and other&#x000a0;antidepressants, morphine, and other opioids</p>
          </list-item>
          <list-item>
            <p>Medications that impair urinary dilution, such as thiazide diuretics</p>
          </list-item>
          <list-item>
            <p>Medications that cause hyponatremia, such as carbamazepine or its analogs, vincristine, nicotine, antipsychotics, chlorpropamide, cyclophosphamide, nonsteroidal anti-inflammatory drugs</p>
          </list-item>
          <list-item>
            <p>Illicit drugs such as methylenedioxymethamphetamine (MDMA or ecstasy).<xref ref-type="bibr" rid="article-23274.r6">[6]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23274.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Hyponatremia is the most common electrolyte disorder, with a prevalence of 20% to 35% among hospitalized patients. The incidence of hyponatremia is high among critical patients in the intensive care unit (ICU) and also in postoperative patients. This is more common in elderly patients due to multiple comorbidities, multiple medications, and a lack of access to food and drinks.<xref ref-type="bibr" rid="article-23274.r9">[9]</xref></p>
      </sec>
      <sec id="article-23274.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Thirst stimulation, antidiuretic hormone (ADH) secretion, and handling of filtered sodium by kidneys maintain serum sodium and osmolality. Normal<bold>&#x000a0;</bold>plasma osmolality is around 275 mOsm/kg to 290 mOsm/kg. To maintain normal osmolality, water intake should be equal to water excretion. The imbalance of water intake and excretion causes hyponatremia or hypernatremia. Water intake is regulated by the thirst mechanism, where osmoreceptors&#x000a0;in the hypothalamus trigger thirst when body osmolality reaches 295 mOsm/kg. Water excretion is tightly regulated by antidiuretic hormone (ADH),&#x000a0;synthesized&#x000a0;in the hypothalamus, and stored in the posterior pituitary gland. Changes in tonicity lead to either enhancement or suppression of ADH secretion. Increased ADH secretion causes reabsorption of water in the kidney, and suppression causes the opposite effect. Baroreceptors in the carotid sinus can also stimulate ADH secretion, but it is less sensitive than the&#x000a0;osmoreceptors. Baroreceptors trigger ADH secretion due to decreased effective circulating volume, nausea, pain, stress, and drugs.<xref ref-type="bibr" rid="article-23274.r10">[10]</xref></p>
        <p>
<bold>Hypertonic Hyponatremia (Serum osmolality of greater than 290&#x000a0;mOsm/kg)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperglycemia</p>
          </list-item>
          <list-item>
            <p>Mannitol</p>
          </list-item>
        </list>
        <p>
<bold>Isotonic Hyponatremia (Serum osmolality between 275&#x000a0;mOsm/kg and 290&#x000a0;mOsm/kg)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pseudo-hyponatremia is a laboratory artifact. It is usually caused by hypertriglyceridemia, cholestasis (lipoprotein X), and hyperproteinemia (monoclonal gammopathy, intravenous immunoglobulin [IVIG]). Two-thirds of clinical labs in use still use indirect ion-selective electrode technology, and therefore this problem is still present.</p>
          </list-item>
          <list-item>
            <p>Nonconductive irrigant solutions: these solutions contain mannitol, glycine, or sorbitol and are used in urological and gynecological procedures such as transurethral resection of the prostate (TURP).<xref ref-type="bibr" rid="article-23274.r11">[11]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Hypotonic Hyponatremia (Serum osmolality of less than 275&#x000a0;mOsm/kg)</bold>
</p>
        <p>Hypotonic hyponatremia represents an excess of free water. This excess free water can be caused by two mechanisms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased free water intake: The patient drinks a large volume of free water (greater than 18 L/day or greater than 750 mL/h) that overwhelms the kidney's capacity to excrete free water. Examples of this are psychogenic polydipsia, marathon runners, water drinking competitions, and ecstasy.</p>
          </list-item>
          <list-item>
            <p>Decreased free water excretion: Patients drink a normal volume of free water, but the kidneys cannot excrete the water&#x000a0;for some reason.</p>
          </list-item>
        </list>
        <p>There are three mechanisms involved in the inability of kidneys to excrete water:</p>
        <p>1. High ADH activity: Three different mechanisms can cause high ADH:</p>
        <list list-type="bullet">
          <list-item>
            <p>Decreased effective arterial blood volume (EABV):&#x000a0;antidiuretic hormone (ADH) is released when there is a reduction of 15% or more of the EABV. This occurs with hypovolemia (e.g., vomiting, diarrhea), decreased cardiac output (e.g., heart failure), or vasodilation (e.g., cirrhosis).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>SIADH: ADH is secreted autonomously. Four general causes of this are brain disorders, lung disorders, drugs (e.g., SSRI), and miscellanea (e.g., nausea and pain).</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cortisol deficiency: Cortisol exerts an inhibitory effect on ADH release. When cortisol is decreased, ADH is&#x000a0;released in large amounts. Adrenal insufficiency is the cause of this mechanism.<xref ref-type="bibr" rid="article-23274.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>2. Low glomerular filtration rate (GFR): a low glomerular filtration rate would impair the kidney's ability to get rid of water. Typical examples are acute kidney injury (AKI), chronic kidney disease (CKD), and end-stage renal disease (ESRD).</p>
        <p>3. Low solute intake:&#x000a0;Patients on a regular diet consume 600 mOsm to 900 mOsm of solute per day. Solutes are defined as substances that are freely filtered by the glomeruli but have relative or absolute difficulty in being reabsorbed by the tubules in relationship to water. The main solutes are urea (which comes from the metabolism of proteins) and electrolytes (e.g., salt). Carbohydrates do not contribute to solute load.&#x000a0;In steady-state conditions, solute intake is equal to urine solute load. Therefore, it is expected that these patients also excrete 600 mOsm to 900 mOsm of solute in the urine. Urine volume, and hence water excretion, is dependent on the urine solute load. The more solute one needs to excrete, the larger the urine volume one needs to produce. The less solute one needs to excrete, the smaller the urine volume one needs to produce. Patients who eat a low amount of solute per day (eg., 200 mOsm/day) on steady-state conditions will also excrete a low amount of solute in the urine, and therefore they will do it in a smaller volume of urine. This decreased urine volume will limit the capacity of the kidneys to excrete water. Typical examples of this are beer potomania and the tea-and-toast diet.</p>
        <p>
<bold>SIADH (Syndrome of inappropriate antidiuretic hormone secretion)</bold>
<xref ref-type="bibr" rid="article-23274.r13">[13]</xref>
</p>
        <p>This is a condition where inappropriate secretion of ADH despite normal or increased plasma volume causes impaired water excretion by the kidney leading to hyponatremia. SIADH is a diagnosis of exclusion, as there is no single test to confirm the diagnosis. Patients are hyponatremic and euvolemic.<xref ref-type="bibr" rid="article-23274.r14">[14]</xref></p>
        <p>Causes of SIADH include</p>
        <list list-type="bullet">
          <list-item>
            <p>Any central nervous system (CNS) disorder,</p>
          </list-item>
          <list-item>
            <p>Ectopic production of ADH (most commonly small cell carcinoma of the lung),</p>
          </list-item>
          <list-item>
            <p>Drugs (carbamazepine, oxcarbazepine, chlorpropamide, and multiple other drugs),</p>
          </list-item>
          <list-item>
            <p>HIV,</p>
          </list-item>
          <list-item>
            <p>Pulmonary diseases (pneumonia, tuberculosis),</p>
          </list-item>
          <list-item>
            <p>Postoperative patients (pain medicated)</p>
          </list-item>
        </list>
        <p>Treatment includes fluid restriction and the use of vasopressin 2 receptor inhibitors.<xref ref-type="bibr" rid="article-23274.r12">[12]</xref><xref ref-type="bibr" rid="article-23274.r15">[15]</xref><xref ref-type="bibr" rid="article-23274.r12">[12]</xref><xref ref-type="bibr" rid="article-23274.r15">[15]</xref><xref ref-type="bibr" rid="article-23274.r12">[12]</xref></p>
      </sec>
      <sec id="article-23274.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Symptoms depend upon the degree and chronicity of hyponatremia. Patients with mild-to-moderate hyponatremia (greater than 120&#x000a0;mEq/L) or a gradual decrease in sodium (greater than 48 hours) have&#x000a0;minimal symptoms. Patients with severe hyponatremia (less than 120&#x000a0;mEq/L) or rapid decrease in sodium levels have multiple varied symptoms.<xref ref-type="bibr" rid="article-23274.r16">[16]</xref></p>
        <p>Symptoms can range from anorexia, nausea and vomiting, fatigue, headache, and muscle cramps to altered mental status, agitation, seizures, and even coma.<xref ref-type="bibr" rid="article-23274.r17">[17]</xref></p>
        <p>Apart from symptoms, a detailed history taking to include a history of pulmonary and CNS disorders, all home medications, and social history (increased beer intake or use of MDM or ecstasy) is very important.</p>
        <p>Physical examination&#x000a0;includes assessing volume status and neurological status.&#x000a0;</p>
        <p>Patients with neurological symptoms and signs need to be&#x000a0;treated promptly to prevent permanent neurological damage.<xref ref-type="bibr" rid="article-23274.r18">[18]</xref></p>
      </sec>
      <sec id="article-23274.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The following steps may be performed while evaluating a patient with suspected hyponatremia<xref ref-type="bibr" rid="article-23274.r19">[19]</xref>:</p>
        <p>
<bold>Step 1: Plasma Osmolality (275 mOsm to 290 mOsm/kg)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>It can help differentiate between hypertonic, isotonic, and hypotonic hyponatremia.</p>
          </list-item>
          <list-item>
            <p>True hyponatremic patients are hypotonic.</p>
          </list-item>
          <list-item>
            <p>If the patient is hypotonic, then go to step 2.</p>
          </list-item>
        </list>
        <p>
<bold>Step 2: Urine Osmolality</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Urine osmolality less than 100 mOsm/kg indicates&#x000a0;primary polydipsia or reset osmostat.</p>
          </list-item>
          <list-item>
            <p>Urine osmolality greater than&#x000a0;100 mOsm/kg usually indicates a high ADH state; go to step 3.</p>
          </list-item>
        </list>
        <p>
<bold>Step 3: Volume Status (ECF status)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypovolemic vs euvolemic vs hypervolemic.</p>
          </list-item>
          <list-item>
            <p>If the patient is hypovolemic, then proceed to step 4.</p>
          </list-item>
        </list>
        <p>
<bold>Step 4: Urine Sodium Concentration</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Urine sodium less than 10 mmol/L&#x000a0;indicates&#x000a0;extrarenal loss of fluid (remote diuretic use and remote vomiting).</p>
          </list-item>
          <list-item>
            <p>Urine sodium greater than 20 mmol/L suggests renal loss of urine (diuretics, vomiting, cortisol deficiency, and salt-wasting nephropathies).</p>
          </list-item>
        </list>
        <p>Other tests that might help in differentiating the causes include</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum thyroid-stimulating hormone (TSH)</p>
          </list-item>
          <list-item>
            <p>Serum&#x000a0;adrenocorticotropic hormone&#x000a0;(ACTH)</p>
          </list-item>
          <list-item>
            <p>Serum urea</p>
          </list-item>
          <list-item>
            <p>Liver function tests</p>
          </list-item>
          <list-item>
            <p>Chest X-ray or computed tomography (CT) scan of the chest</p>
          </list-item>
          <list-item>
            <p>CT scan of the head</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23274.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of hyponatremia depends upon the degree of&#x000a0;hyponatremia, duration of hyponatremia, severity of symptoms, and volume status.</p>
        <p>
<bold>Acute Symptomatic Hyponatremia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Severely symptomatic hyponatremia: Administer 3% sodium chloride; 100 mL intravenous (IV) bolus (repeat up to twice if symptoms persist).</p>
          </list-item>
          <list-item>
            <p>Mild to moderately symptomatic hyponatremia: 3% Sodium chloride, slow infusion (use sodium deficit formula to calculate the rate of infusion but recalculate rate with frequent sodium monitoring).</p>
          </list-item>
        </list>
        <p>
<bold>Chronic Asymptomatic Hyponatremia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypovolemic hyponatremia: Isotonic fluids administration and holding of any diuretics.</p>
          </list-item>
          <list-item>
            <p>Hypervolemic hyponatremia: Treat underlying condition, restrict salt and fluids, and administer loop diuretics.</p>
          </list-item>
          <list-item>
            <p>Euvolemic hyponatremia: Fluid restriction to less than 1 liter per day.</p>
          </list-item>
        </list>
        <p>Drugs: Selective vasopressin 2 receptor antagonists are being&#x000a0;used recently. They increase the excretion of water in the kidneys without affecting sodium, thereby increasing serum sodium levels. These medications are used in patients with euvolemic and hypervolemic conditions (except liver failure) if the above measure does not help.<xref ref-type="bibr" rid="article-23274.r20">[20]</xref><xref ref-type="bibr" rid="article-23274.r21">[21]</xref></p>
        <p>The goal of correction: Correct sodium by no more than&#x000a0;10 mEq/L to 12&#x000a0;mEq/L in any 24-hour period.</p>
        <p>Risk factors for osmotic demyelination syndrome (ODS): Hypokalemia, liver disease, malnutrition, and alcohol use.</p>
        <p>
<bold>Limits of Correction</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>High-risk for ODS: less than 8 mEq/L in any 24-hour period</p>
          </list-item>
          <list-item>
            <p>Average risk for ODS: less than 10 mEq/L in any 24-hour period</p>
          </list-item>
        </list>
        <p>In the absence of false laboratory hyponatremia, pseudo hyponatremia, and a lack of hypovolemic state, including postural hypotension, the next step is to measure urine sodium and osmolarity. In the low urinary sodium of less than 100 mOsm/kg and absence of rapid water consumption, the potential for a high fluid, low protein diet, including beer potomania, should be examined. In patients with severe hyponatremia of less than 120 mEq/L, the chronicity of the hyponatremia should be considered. Accordingly, in severe, chronic hyponatremia, intravenous 3 percent saline at a rate of 15 to 30 mL/hour should be initiated. In some patients, desmopressin (dDAVP) should also be administered to prevent overly rapid correction.</p>
        <p>Three percent saline can be safely infused via a peripheral vein, and so far, vascular thrombosis and extravasation injuries have not been reported. However, some centers have policies against the peripheral infusion of hypertonic saline. In these circumstances, central vein infusions or infusions of a lower concentration with higher infusion rates are required.&#x000a0;&#x000a0;Tolvaptan is indicated in hyponatremia associated with high anti-diuretic hormone (ADH) activity.</p>
        <p>Fluid restriction is adequate for patients who have normovolemic hypotonic hyponatremia. Some patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH) who are malnourished may need a high protein intake, which increases the solute load for renal excretion, resulting in more free water removal. Laboratory findings in patients with SIADH reveal hyponatremia (plasma sodium level of less than 135 mEq/L) and low serum osmolality (less than 280 mOsm/kg). Moreover, patients with SIADH have increased urinary sodium levels (greater than 20 mMol/L) and urine osmolality (generally above 100 mOsm/L).<xref ref-type="bibr" rid="article-23274.r22">[22]</xref></p>
      </sec>
      <sec id="article-23274.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>True hyponatremia is associated with hypo osmolality. Conditions causing hyperosmolar hyponatremia&#x000a0;and iso-osmolar hyponatremia (pseudo-hyponatremia) should be differentiated first.<xref ref-type="bibr" rid="article-23274.r23">[23]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperglycemia</p>
          </list-item>
          <list-item>
            <p>Mannitol overdose</p>
          </list-item>
          <list-item>
            <p>Hyperlipidemia</p>
          </list-item>
          <list-item>
            <p>Hyperproteinemia</p>
          </list-item>
        </list>
        <p>
<bold>Differential Diagnosis for Hypo-Osmolar Hyponatremia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastroenteritis</p>
          </list-item>
          <list-item>
            <p>Diuretic use</p>
          </list-item>
          <list-item>
            <p>Congestive heart failure</p>
          </list-item>
          <list-item>
            <p>Liver failure</p>
          </list-item>
          <list-item>
            <p>Psychogenic polydipsia</p>
          </list-item>
          <list-item>
            <p>Renal causes</p>
          </list-item>
          <list-item>
            <p>SIADH</p>
          </list-item>
          <list-item>
            <p>Adrenal crisis</p>
          </list-item>
          <list-item>
            <p>Hypothyroidism</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23274.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis in patients with hyponatremia depends on the severity of hyponatremia and the underlying condition causing it. The prognosis is poor in patients with severe hyponatremia, acute hyponatremia, and older patients.<xref ref-type="bibr" rid="article-23274.r24">[24]</xref></p>
      </sec>
      <sec id="article-23274.s11" sec-type="Complications">
        <title>Complications</title>
        <p>If left untreated or inadequately treated, patients with hyponatremia can develop rhabdomyolysis, altered mental status, seizures, and even coma.</p>
        <p>Rapid correction of chronic hyponatremia (greater than 10 mEq/L to 12 mEq/L of sodium in 24 hrs) can lead to osmotic demyelination syndrome.</p>
        <p>Osmotic demyelination syndrome, formerly&#x000a0;known as central pontine myelinolysis, is a complication of rapid correction of sodium in patients with chronic hyponatremia.<xref ref-type="bibr" rid="article-23274.r25">[25]</xref> In patients with hyponatremia, the brain adapts to a fall in serum sodium level, without developing cerebral edema, in about&#x000a0;48 hours. As a result, patients with chronic hyponatremia are mostly asymptomatic. Once the brain adapts to low serum sodium, the rapid correction of sodium leads to osmotic demyelination syndrome. Clinical manifestations are typically delayed by a few days and comprise&#x000a0;several irreversible neurological symptoms, including seizures, disorientation, and even coma. "Locked-in" syndrome occurs in severely affected patients. These patients are awake but unable to move or can communicate with the help of their eyes only.<xref ref-type="bibr" rid="article-23274.r26">[26]</xref></p>
      </sec>
      <sec id="article-23274.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>It is imperative to consult&#x000a0;a nephrologist in a patient with severe hyponatremia or a rapid decrease in sodium, or persistent hyponatremia.</p>
        <p>Cardiology and gastroenterology consultation might be necessary for patients with congestive heart failure and hepatic failure, respectively.</p>
      </sec>
      <sec id="article-23274.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with hyponatremia should be followed closely at discharge by both the primary care provider and nephrology. Follow-up labs are ordered as needed, and patients needing fluid restriction should be educated appropriately.<xref ref-type="bibr" rid="article-23274.r27">[27]</xref></p>
      </sec>
      <sec id="article-23274.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Hyponatremia is a common electrolyte abnormality.</p>
          </list-item>
          <list-item>
            <p>Hyponatremia can range from an asymptomatic condition to a life-threatening condition.</p>
          </list-item>
          <list-item>
            <p>Hyponatremia can occur with hypovolemic or hypervolemic or euvolemic states.</p>
          </list-item>
          <list-item>
            <p>Common causes include diuretics, vomiting, diarrhea,&#x000a0;congestive heart failure, renal and liver disease.</p>
          </list-item>
          <list-item>
            <p>Degree, and duration of hyponatremia, along with the severity of symptoms, determine the management algorithm and the rapidity to correct sodium.</p>
          </list-item>
          <list-item>
            <p>Do not correct the hyponatremia by more than&#x000a0;10 mEq/L to 12&#x000a0;mEq/L in 24 hours, except in patients with severe symptoms and rapidly decreased sodium levels.</p>
          </list-item>
          <list-item>
            <p>Too rapid correction of the sodium levels can lead to osmotic demyelinating syndrome.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23274.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hyponatremia is a common electrolyte abnormality. Sodium levels need to be closely monitored, as this could lead to life-threatening complications if left untreated. This is even more important in patients with renal disease and those who are on diuretics. Good interprofessional communication between the primary care provider and a nephrologist is imperative to keep a close eye on sodium levels and their proper correction as and when needed.</p>
      </sec>
      <sec id="article-23274.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23274&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23274">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/hyponatremia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23274">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23274/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23274">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23274.s17">
        <title>References</title>
        <ref id="article-23274.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Overgaard-Steensen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Initial approach to the hyponatremic patient.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-48</page-range>
            <pub-id pub-id-type="pmid">21029052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Overgaard-Steensen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bluhme</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>T&#x000f8;nnesen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fr&#x000f8;kiaer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ring</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Edelman's equation is valid in acute hyponatremia in a porcine model: plasma sodium concentration is determined by external balances of water and cations.</article-title>
            <source>Am J Physiol Regul Integr Comp Physiol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>298</volume>
            <issue>1</issue>
            <fpage>R120</fpage>
            <page-range>R120-9</page-range>
            <pub-id pub-id-type="pmid">19864338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoorn</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Zietse</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2017</year>
            <month>May</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>1340</fpage>
            <page-range>1340-1349</page-range>
            <pub-id pub-id-type="pmid">28174217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verbalis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Korzelius</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schrier</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Sterns</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.</article-title>
            <source>Am J Med</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>126</volume>
            <issue>10 Suppl 1</issue>
            <fpage>S1</fpage>
            <page-range>S1-42</page-range>
            <pub-id pub-id-type="pmid">24074529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spasovski</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vanholder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bichet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Decaux</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fenske</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hoorn</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Ichai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Joannidis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soupart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zietse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Veer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Biesen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Nagler</surname>
                <given-names>E</given-names>
              </name>
              <collab>Hyponatraemia Guideline Development Group</collab>
            </person-group>
            <article-title>Clinical practice guideline on diagnosis and treatment of hyponatraemia.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>29 Suppl 2</volume>
            <fpage>i1</fpage>
            <page-range>i1-i39</page-range>
            <pub-id pub-id-type="pmid">24569496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Barstow</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pyzocha</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of sodium disorders: hyponatremia and hypernatremia.</article-title>
            <source>Am Fam Physician</source>
            <year>2015</year>
            <month>Mar</month>
            <day>01</day>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>299</fpage>
            <page-range>299-307</page-range>
            <pub-id pub-id-type="pmid">25822386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mahowald</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Electrolytes: Sodium Disorders.</article-title>
            <source>FP Essent</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>459</volume>
            <fpage>11</fpage>
            <page-range>11-20</page-range>
            <pub-id pub-id-type="pmid">28806046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barstow</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Electrolytes: Calcium Disorders.</article-title>
            <source>FP Essent</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>459</volume>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">28806048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burst</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Etiology and Epidemiology of Hyponatremia.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>52</volume>
            <fpage>24</fpage>
            <page-range>24-35</page-range>
            <pub-id pub-id-type="pmid">32097911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rondon-Berrios</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Agaba</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Tzamaloukas</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Hyponatremia: pathophysiology, classification, manifestations and management.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>11</issue>
            <fpage>2153</fpage>
            <page-range>2153-65</page-range>
            <pub-id pub-id-type="pmid">25248629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darwish</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Lutnick</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dalimov</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Waisanen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Houjaij</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nader</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Neuraxial vs General Anesthesia: 30-Day Mortality Outcomes Following Transurethral Resection of Prostate.</article-title>
            <source>Urology</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>157</volume>
            <fpage>274</fpage>
            <page-range>274-279</page-range>
            <pub-id pub-id-type="pmid">34274392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Groh&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Berardi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Runkle</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>SIADH: differential diagnosis and clinical management.</article-title>
            <source>Endocrine</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>311</fpage>
            <page-range>311-319</page-range>
            <pub-id pub-id-type="pmid">27025948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burnier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Approach to the syndrome of inappropriate antidiuretic hormone secretion (SIADH)].</article-title>
            <source>Rev Med Suisse</source>
            <year>2018</year>
            <month>Nov</month>
            <day>21</day>
            <volume>14</volume>
            <issue>628</issue>
            <fpage>2116</fpage>
            <page-range>2116-2120</page-range>
            <pub-id pub-id-type="pmid">30462399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Las Pe&#x000f1;as</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ponce</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Henao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Camps Herrero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carcereny</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Escobar &#x000c1;lvarez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Virizuela</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez L&#x000f3;pez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.</article-title>
            <source>Support Care Cancer</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>499</fpage>
            <page-range>499-507</page-range>
            <pub-id pub-id-type="pmid">26431960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shepshelovich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schechter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calvarysky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Diker-Cohen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rozen-Zvi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gafter-Gvili</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Medication-induced SIADH: distribution and characterization according to medication class.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>83</volume>
            <issue>8</issue>
            <fpage>1801</fpage>
            <page-range>1801-1807</page-range>
            <pub-id pub-id-type="pmid">28168757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tazmini</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ranhoff</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Electrolyte outpatient clinic at a local hospital - experience from diagnostics, treatment and follow-up.</article-title>
            <source>BMC Health Serv Res</source>
            <year>2020</year>
            <month>Feb</month>
            <day>28</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>154</fpage>
            <pub-id pub-id-type="pmid">32111205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohottige</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lehrich</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypovolemic Hyponatremia.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>52</volume>
            <fpage>93</fpage>
            <page-range>93-103</page-range>
            <pub-id pub-id-type="pmid">32097947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Morbidity and Mortality of Hyponatremia.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>52</volume>
            <fpage>36</fpage>
            <page-range>36-48</page-range>
            <pub-id pub-id-type="pmid">32097927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filippatos</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Liamis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Christopoulou</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elisaf</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Ten common pitfalls in the evaluation of patients with hyponatremia.</article-title>
            <source>Eur J Intern Med</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>29</volume>
            <fpage>22</fpage>
            <page-range>22-5</page-range>
            <pub-id pub-id-type="pmid">26706473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rondon-Berrios</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Berl</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>07</day>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>2268</fpage>
            <page-range>2268-78</page-range>
            <pub-id pub-id-type="pmid">26109207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Mise</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Venneri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Centrone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tamma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Valenti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells.</article-title>
            <source>Int J Mol Sci</source>
            <year>2019</year>
            <month>Dec</month>
            <day>26</day>
            <volume>21</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31888044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krisanapan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vongsanim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pin-On</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ruengorn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Noppakun</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Furosemide, Oral Sodium Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label Randomized Controlled Study (The EFFUSE-FLUID Trial).</article-title>
            <source>Am J Kidney Dis</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-212</page-range>
            <pub-id pub-id-type="pmid">32199708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Girot</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>D&#x000e9;hais</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fraissinet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wils</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brunel</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Atypical Pseudohyponatremia.</article-title>
            <source>Clin Chem</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>414</fpage>
            <page-range>414-415</page-range>
            <pub-id pub-id-type="pmid">29378746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>C</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Badiger</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Hyponatraemia Among Elderly Patients with Lower Respiratory Tract Infection.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <pub-id pub-id-type="pmid">31979779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sterns</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Adverse Consequences of Overly-Rapid Correction of Hyponatremia.</article-title>
            <source>Front Horm Res</source>
            <year>2019</year>
            <volume>52</volume>
            <fpage>130</fpage>
            <page-range>130-142</page-range>
            <pub-id pub-id-type="pmid">32097948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reijnders</surname>
                <given-names>TDY</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>WMT</given-names>
              </name>
              <name>
                <surname>Niamut</surname>
                <given-names>SML</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Role of Risk Factors in Developing Osmotic Demyelination Syndrome During Correction of Hyponatremia: A Case Study.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Jan</month>
            <day>02</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>e6547</fpage>
            <pub-id pub-id-type="pmid">32042522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23274.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golestaneh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Neugarten</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Southern</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kargoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Raff</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>491</fpage>
            <page-range>491-497</page-range>
            <pub-id pub-id-type="pmid">28091865</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
